Momenta Pharmaceuticals (MNTA -2.6%) is trading down after reporting a Q4 net loss, reversing...

|About: Momenta Pharmaceuticals, Inc. (MNTA)|By:, SA News Editor

Momenta Pharmaceuticals (MNTA -2.6%) is trading down after reporting a Q4 net loss, reversing year-ago gains and missing forecasts. Revenue plummeted 49% Y/Y on lower sales of enoxaparin, a key customer's drug used to treat blocked arteries.